Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposing the hidden: establishing immunity to Plasmodium liver stage infection.

Trends in parasitology·2025
Same author

Plasmodium falciparum gametogenesis essential protein 1 (GEP1) is a transmission-blocking target.

FEBS letters·2025
Same author

Stage-dependent expression and vacuolar localization of Plasmodium berghei chloroquine resistance transporter (CRT).

Molecular and biochemical parasitology·2025
Same author

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.

EMBO molecular medicine·2025
Same author

Negative Perception of Bats, Exacerbated by the SARS-CoV-2 Pandemic, May Hinder Bat Conservation in Northern Uganda.

Sustainability·2025
Same author

Red pulp macrophages clear parasites, while marginal metallophilic and marginal zone macrophages support CD4<sup>+</sup> T cell activation during <i>Plasmodium yoelii</i> infection.

Frontiers in immunology·2025

Related Experiment Video

Updated: May 15, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

Murine infection models for vaccine development: the malaria example.

Kai Matuschewski1

  • 1Parasitology Unit; Max Planck Institute for Infection Biology; Berlin, Germany; Institute of Biology; Humboldt University; Berlin, Germany.

Human Vaccines & Immunotherapeutics
|December 20, 2012
PubMed
Summary

Malaria vaccine development utilizes experimental infections in humans and mice. Challenge studies with Plasmodium parasites are crucial for evaluating vaccine safety and efficacy, guiding future malaria vaccine strategies.

More Related Videos

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
08:23

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages

Published on: May 30, 2019

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Related Experiment Videos

Last Updated: May 15, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
08:23

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages

Published on: May 30, 2019

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Area of Science:

  • Vaccinology
  • Infectious Diseases
  • Parasitology

Background:

  • Malaria is a fatal, vector-borne disease caused by Plasmodium parasites.
  • Pathogen stage conversion enables novel vaccine strategies.
  • Experimental human challenge infections with Plasmodium falciparum are vital for vaccine studies.

Purpose of the Study:

  • To discuss the integration of challenge experiments with Plasmodium parasites into malaria vaccine development.
  • To highlight the importance of preclinical assessment in prioritizing vaccine candidates.
  • To explore opportunities in advancing malaria vaccine approaches.

Main Methods:

  • Utilizing experimental homologous challenge infections in humans for Phase II vaccine studies.
  • Employing murine infection models for preclinical assessment and prioritization of vaccine candidates.
  • Developing whole organism vaccine approaches using live attenuated parasites.

Main Results:

  • Demonstration of safety and lasting sterile protection are key endpoints for advancing vaccine candidates.
  • Preclinical challenge studies in mice have informed the development of whole organism vaccines.
  • Live attenuated parasites educate T cells to target developing Plasmodium parasites.

Conclusions:

  • Challenge experiments, particularly with murine Plasmodium species, offer valuable insights for malaria vaccine development.
  • Integrating preclinical challenge studies enhances the selection and prioritization of vaccine candidates.
  • Further exploration of challenge models can accelerate the development of effective malaria vaccines.